The combination of CALR and PDIA3 has also been suggested as a possible prognostic biomarker for non-small-cell lung cancer [23], with PDIA6 modulating apoptosis and autophagy of non-small-cell lung cancer cells via the MAP4K1/JNK signalling pathway [24]. This evidence concerns the gene PDIA6 and non-small cell lung carcinoma.